Clinical Trial Update: Trans Sodium Crocetinate (TSC) Study of Intra-tumoral Oxygen Concentration, Safety, and Pharmacokinetics in Patients With High Grade Glioma [Phase 1]

View source ↗

Summary

A Phase 1 study of Trans Sodium Crocetinate (TSC) in patients with high-grade glioma has been terminated. The update covers intra-tumoral oxygen concentration, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Glioma

Drugs mentioned

• Trans Sodium Crocetinate (trans-sodium crocetinate)

Snippet

Sponsor: Diffusion Pharmaceuticals Inc | Conditions: High Grade Glioma | Phase 1 | Status: TERMINATED